Overview

Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
A relative bioavailability study of commercial palbociclib free base hard capsules to the isethionate salt palbociclib capsules ( used in Phase 1 and 2 studies) under different fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Palbociclib